Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691769 · ClinicalTrials.gov registry record
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
A clinical trial, sponsored by Wake Forest University.
- Completed
- Registry status
- 8
- Enrollment target
NCT00691769: Completed study, sponsored by Wake Forest University.
NCT00691769 is a clinical trial that has completed, run by Wake Forest University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00691769 has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-04-26 |
| Est. Completion | 2012-11-26 |
What the finished NCT00691769 record still lists
NCT00691769 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00691769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00691769 about?
NCT00691769 is a clinical study titled "Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia". The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
What is the current status of trial NCT00691769?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2006-04-26. Estimated completion is 2012-11-26.
Who is sponsoring clinical trial NCT00691769?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI